Skip to content
StockMarketAgent
Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

BVMF/I1DX34 stock hub

BVMF/I1DX34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/I1DX34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
216.4B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/I1DX34
In the news

Latest news · BVMF/I1DX34

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E36.9
P25 11.3P50 14.6P75 19.6
Trailing P/E37.9
P25 15.2P50 21.5P75 27.3
ROE72.9
P25 5.3P50 12.3P75 22.5
ROIC46
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/I1DX34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
212
Groups with data
11
Currency
USD
Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
BR
Employees
11,000
Employees Change
0%
Employees Change Percent
0
Enterprise value
BRL 220.8B
Exchange
Brazil Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Diagnostics & Research
Last refreshed
2026-05-10
Market cap
BRL 216.4B
Price
BRL 565
Price currency
BRL
Rev Per Employee
2,108,550.45x
Sector
Healthcare
Sic
2835
Symbol
bvmf/I1DX34
Website
https://www.idexx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
2.64%
EV Earnings
38.65x
EV/EBIT
32.27x
EV/EBITDA
28.44x
EV/FCF
39.07x
EV/Sales
10.14x
FCF yield
2.61%
Forward P/E
36.89x
P/B ratio
26.66x
P/E ratio
37.87x
P/S ratio
9.33x
PE Ratio10 Y
53.41x
PE Ratio3 Y
46.67x
PE Ratio5 Y
51.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
31.42%
EBITDA Margin
34.77%
FCF margin
24.37%
Gross margin
62.05%
Gross Profit
BRL 14.4B
Gross Profit Growth
14.52%
Gross Profit Growth Q
15.94%
Gross Profit Growth3 Y
10.43%
Gross Profit Growth5 Y
10.4%
Net Income
BRL 5.7B
Net Income Growth
22.38%
Net Income Growth Q
14.74%
Net Income Growth3 Y
16.14%
Net Income Growth5 Y
10.19%
Pretax Margin
30.8%
Profit Margin
24.63%
Profit Per Employee
BRL 519,412
ROA
26.46
Roa5y
23.48
ROCE
66.99
ROE
72.92
Roe5y
84.36
ROIC
45.95
Roic5y
45.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

20
MetricValue
Cagr1y
3.03%
Cagr3y
6%
Cagr5y
0.12%
EPS Growth
25.7
EPS Growth Q
17.23
EPS Growth3 Y
17.86
EPS Growth5 Y
11.83
FCF Growth
27.81%
FCF Growth Q
12.66%
FCF Growth3 Y
33.47%
FCF Growth5 Y
10.21%
OCF Growth
24.96%
OCF Growth Q
11.89%
OCF Growth10 Y
16.71%
OCF Growth3 Y
25.5%
OCF Growth5 Y
10.2%
Revenue Growth
13.08x
Revenue Growth Q
14.26x
Revenue Growth3 Y
9.02x
Revenue Growth5 Y
9.24x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
BRL 1.35
Assets
BRL 17.7B
Cash
BRL 1B
Current Assets
BRL 7.1B
Current Liabilities
BRL 6.4B
Debt
BRL 5.8B
Debt EBITDA
BRL 0.7
Debt Equity
BRL 0.71
Debt FCF
BRL 1.02
Equity
BRL 8.1B
Interest Coverage
35.89
Liabilities
BRL 9.5B
Long Term Assets
BRL 10.5B
Long Term Liabilities
BRL 3.2B
Net Cash
BRL -4.7B
Net Cash By Market Cap
BRL -2.18
Net Debt EBITDA
BRL 0.59
Net Debt Equity
BRL 0.58
Net Debt FCF
BRL 0.84
Tangible Book Value
BRL 5.4B
Tangible Book Value Per Share
BRL 68.42
WACC
12.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.12
Inventory Turnover
4.34
Net Working Capital
BRL 3.4B
Quick ratio
0.69
Working Capital
BRL 804.5M
Working Capital Turnover
BRL 138

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
2.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
3.03%
200-day SMA
584.9
3Y total return
19.11%
50-day SMA
648.4
50-day SMA vs 200-day SMA
50over200
5Y total return
0.58%
All Time High
813.6
All Time High Change
-30.6%
All Time High Date
2025-11-24
All Time Low
225.1
All Time Low Change
150.87%
All Time Low Date
2020-02-28
ATR
10.58
Beta
1.57
Ch YTD
-25.25
High
564.6
High52
813.6
High52 Date
2025-11-24
High52ch
-30.6%
Low
564.6
Low52
550
Low52 Date
2026-04-29
Low52ch
2.66%
Ma50ch
-12.93%
Price vs 200-day SMA
-3.48%
RSI
33.51
RSI Monthly
45.98
RSI Weekly
43.3
Sharpe ratio
0.87x
Sortino ratio
1.76
Total Return
2.6%
Tr YTD
-25.25
Tr1m
-5.47%
Tr1w
1.28%
Tr3m
-16.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
BRL 7.3B
Operating Income Growth
14.85
Operating Income Growth Q
11.38
Operating Income Growth3 Y
14.49
Operating Income Growth5 Y
11.86
Operating margin
31.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
78,012,659%
Net Borrowing
157,819,533
Shares Insiders
0.99%
Shares Institutions
94.38%
Shares Qo Q
-0.4%
Shares Yo Y
-2.6%
Short Ratio
3.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
BRL 5.3B
Average Volume
48x
Bv Per Share
102.4
CAPEX
BRL -660.6M
Ch1m
-5.47
Ch1w
1.28
Ch1y
3.03
Ch3m
-16.94
Ch3y
19.11
Ch5y
0.58
Ch6m
-25.61
Change
-0.55%
Change From Open
0
Close
567.7
Days Gap
-0.55
Depreciation Amortization
731,247,702.6
Dollar Volume
564.6
Earnings Date
2026-05-05
EBIT
BRL 7.3B
EBITDA
BRL 8.1B
EPS
BRL 70.92
F Score
7
FCF
BRL 5.7B
FCF EV Yield
2.56x
Financing CF
-5,457,075,171
Fiscal Year End
December
Founded
1,983
Goodwill
2,025,161,476.8
Graham Number
84.28736
Graham Upside
-85.07
Income Tax
BRL 1.4B
Investing CF
-731,243,993
Is Primary Listing
0
Last Earnings Date
2026-05-05
Last Report Date
2026-03-31
Lynch Fair Value
BRL 152
Lynch Upside
-73.09
Ma150
606
Ma150ch
-6.84%
Ma20
578.2
Ma20ch
-2.36%
Net CF
190,713,033
Open
564.6
P FCF Ratio
38.29
P OCF Ratio
34.28
Ppne
4,234,944,533.4
Price Date
2026-05-07
Price EBITDA
BRL 26.83
Ptbv Ratio
39.91
Relative Volume
0.02x
Revenue
23,194,054,939x
SBC By Revenue
1.39x
Share Based Comp
322,070,168
Tax By Revenue
6.17x
Tax Rate
20.03%
Tr6m
-25.61%
Volume
1
Z Score
21.31
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVMF/I1DX34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/I1DX34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+3.0%
S&P 500 1Y: n/a
3Y total return
+19.1%
S&P 500 3Y: n/a
5Y total return
+0.6%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVMF/I1DX34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+94.4%
Share of float held by funds and institutions
Insider ownership
+1.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.9 days to cover
Y/Y dilution
-2.6%
Negative means the company is buying back shares.
Technical

BVMF/I1DX34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
33.5
Neutral momentum band
Price vs 200-day MA
-3.5%
50/200-day relationship not available
Beta (5Y)
1.57
More volatile than the market
Sharpe ratio
0.87
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/I1DX34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/I1DX34 stock rating?

bvmf/I1DX34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/I1DX34 analysis?

The full report lives at /stocks/bvmf/I1DX34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/I1DX34?

The latest report frames bvmf/I1DX34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/I1DX34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.